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GFR decline than diets low in acid-inducing amino acids.
As Western diets are generally acid-inducing on balance6
and because of the difficulty faced by clinicians in effecting
major diet changes in our patients, we suggest that a more
practical hypothesis to test is whether adding non-food
alkali such as NaHCO3 or Na
þ Citrate to the usual western
diet will slow the rate of GFR decline in CKD subjects
eating a standard western diet. If this intervention slows,
prevents, or stops GFR decline, this would be a compara-
tively inexpensive addition to the armamentarium of
strategies to slow or stop CKD progression toward
complete kidney failure.
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To the Editor: I read with great interest the article by
Swaminathan et al.1 presenting the importance of high
mortality in nephrogenic systemic fibrosis (NSF) and
providing evidence that the short survival of these patients
could be attributed to metal accumulation (gadolinium,
aluminum, iron) in several inner organs, including heart and
blood vessels. Although I completely agree with the authors,
who wrote that they ‘ypresent several novel observations’
despite the fact that ‘there are several limitations’,1 some
information is missing. For example, it would be interesting
to know which Gd-containing contrast agents (GCCA) the
patients received, and whether there was a difference in
applied substances in patients who died and who are still
alive.
As previously described, both transmetalation of GCCA
and association with NSF are preferentially observed along
with nonionic linear compounds.2–4 In contrast, macrocyclic
compounds have up to now not been demonstrated as
causing NSF.4
Uncertainty about the chemical nature of GCCA used in
patients who developed NSF and eventually died due to
cardiac and vascular events limits our understanding of the
disease and thus hampers efforts to prevent it.
Furthermore, of the 32 patients with NSF studied, Table 1
presented only data of the 10 patients who died.1 What are
the demographics, and clinical conditions of the 22
remaining patients? In particular, it would be very interesting
to know whether these two groups were different in some
aspect.
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